Funding drugs and other health technologies

Our response to NICE and NHS England's consultation on changes to funding arrangements

29 January 2017

NICE and NHS England launched a consultation in Autumn 2016 on changes proposed  to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programmes.

We argued that the NHS needs to become more adept at phasing in new treatments and technologies that are proven to be cost-effective, and disinvesting in outdated lower-value activities.

We also recognised that introducing new technologies can cause disruption to existing services but in times of financial constraint the need to encourage innovation, and shift resources to higher-value activities, is even more urgent.

Furthermore, we argued if the NHS has to prioritise new technologies in a period of financial constraint it should prioritise treatments and technologies by their relative cost-effectiveness, rather than their budgetary impact.

You might also like...

Press release

Preparing health care workforce for a digital future will require Herculean effort at all levels

Health Foundation response to The Topol Review on preparing the health care workforce for a digital future.


How has the productivity of UK health care changed between 1997 and 2016?

January 2019 Chart of the Month. Between 1997 and 2016, productivity across the UK NHS grew by 20%, at an average of around 1...

Improvement project

Developing home-based Parkinson’s care

This project will introduce a new way of working for Parkinson's nurses, that better meets the needs of patients and improves...

Kjell-bubble-diagramArtboard 101

Work with us

We look for talented and passionate individuals as everyone at the Health Foundation has an important role to play.

View current vacancies
Artboard 101 copy 2

The Q Community

Q is an initiative connecting people with improvement expertise across the UK.

Find out more